Élévation

Journal — Élévation

Toutes les publications éditoriales Élévation : guides, comparatifs et conseils experts pour bien choisir.

Why Invest in a Reclining Chair?

A reclining chair is not just furniture: it's a health investment that reduces falls by 40%, extends home independence by 2-3 years and relieves caregivers. Discover the concrete ROI.

When to Switch to a Recliner Chair? 8 Key Signals

A recliner chair is not a luxury but a valuable aid at the right time. Discover the 8 signals that indicate it's time to take the step.

Medical Opinion: Recliner Chair Recommended or Not?

Healthcare professionals recommend the recliner chair for osteoarthritis, hip prostheses and Parkinson's disease. Discover the indications, contraindications and medical standards.

Riser Recliner Chair Price: Real Budget 2025

How much does a riser recliner chair really cost in France? Discover the 2025 pricing grid: from €600 to €4500 depending on options, plus available financial aid and reimbursements.

How to Choose Your Recliner Chair in 7 Steps

Discover the 7-step method to select the recliner chair suited to your needs: space evaluation, mobility, motorization and budget. Checklist included.

Second-Hand Reclining Chair: Good Deal or Risk?

The second-hand market offers savings up to 50% on reclining chairs. Discover how to verify the structure, motor and warranties to avoid unpleasant surprises.

Leather Recliner Chair: Elegance & Durability

The leather recliner chair combines timeless elegance and exceptional durability. Explore leather types, stain-resistant treatments, specific care and premium alternatives for luxury comfort.

Compact Recliner Chair: Space-Saving Solutions

Discover the best compact recliner chair solutions for small spaces. Dimensions under 80 cm, high-performance lifting mechanism and urban design for seniors.

Reclining Chair Reimbursement: Your Rights 2025

Reclining chair reimbursement depends on your medical situation and country of residence. In France, Social Security reimburses up to 90% via LPPR, subject to medical prescription and ALD eligibility.